Sickle cell disease
RE Ware, M de Montalembert, L Tshilolo, MR Abboud - The Lancet, 2017 - thelancet.com
Sickle cell disease is a common and life-threatening haematological disorder that affects
millions of people worldwide. Abnormal sickle-shaped erythrocytes disrupt blood flow in small …
millions of people worldwide. Abnormal sickle-shaped erythrocytes disrupt blood flow in small …
[HTML][HTML] Hydroxyurea for children with sickle cell anemia in sub-Saharan Africa
L Tshilolo, G Tomlinson, TN Williams… - … England Journal of …, 2019 - Mass Medical Soc
Background Hydroxyurea is an effective treatment for sickle cell anemia, but few studies
have been conducted in sub-Saharan Africa, where the burden is greatest. Coexisting …
have been conducted in sub-Saharan Africa, where the burden is greatest. Coexisting …
Neonatal screening for sickle cell anaemia in the Democratic Republic of the Congo: experience from a pioneer project on 31 204 newborns
L Tshilolo, LM Aissi, D Lukusa, C Kinsiama… - Journal of clinical …, 2009 - jcp.bmj.com
Background: Despite the high prevalence of sickle cell disease in Africa, a neonatal
screening programme is available in only a few countries in the sub-Saharan region. Aim: To …
screening programme is available in only a few countries in the sub-Saharan region. Aim: To …
Assessment of clinical outcomes among children and adolescents hospitalized with COVID-19 in 6 sub-Saharan African countries
…, RJ Deckelbaum, MG Fowler, L Tshilolo… - JAMA …, 2022 - jamanetwork.com
Importance Little is known about COVID-19 outcomes among children and adolescents in
sub-Saharan Africa, where preexisting comorbidities are prevalent. Objective To assess the …
sub-Saharan Africa, where preexisting comorbidities are prevalent. Objective To assess the …
Hydroxyurea therapy for children with sickle cell anemia in sub‐saharan africa: rationale and design of the REACH trial
PT McGann, L Tshilolo, B Santos… - Pediatric Blood & …, 2016 - Wiley Online Library
Background Sickle cell anemia (SCA) is an inherited hematological disorder that causes a
large but neglected global health burden, particularly in Africa. Hydroxyurea represents the …
large but neglected global health burden, particularly in Africa. Hydroxyurea represents the …
Neonatal screening and clinical care programmes for sickle cell disorders in sub-Saharan Africa: lessons from pilot studies
L Tshilolo, E Kafando, M Sawadogo, F Cotton… - Public health, 2008 - Elsevier
OBJECTIVES: Despite the widespread use of neonatal screening programmes for sickle cell
disease in Western regions, few studies have focused on the special healthcare needs in …
disease in Western regions, few studies have focused on the special healthcare needs in …
Empowering newborn screening programs in African countries through establishment of an international collaborative effort
…, K Ouldim, MC Rahimy, B Santos, L Tshilolo… - Journal of Community …, 2020 - Springer
In an effort to explore new knowledge and to develop meaningful collaborations for improving
child health, the First Pan African Workshop on Newborn Screening was convened in …
child health, the First Pan African Workshop on Newborn Screening was convened in …
Hydroxyurea treatment is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa
Realizing Effectiveness Across Continents with Hydroxyurea (REACH, NCT01966731 ) provides
hydroxyurea at maximum tolerated dose (MTD) for children with sickle cell anemia (SCA…
hydroxyurea at maximum tolerated dose (MTD) for children with sickle cell anemia (SCA…
Estimating the risk of child mortality attributable to sickle cell anaemia in sub-Saharan Africa: a retrospective, multicentre, case-control study
…, DA Diallo, A Tolo, E Kafando, L Tshilolo… - The Lancet …, 2022 - thelancet.com
Background Many children with sickle cell disease living in sub-Saharan Africa die before
reaching age 5 years. We estimate the child mortality associated with sickle cell anaemia …
reaching age 5 years. We estimate the child mortality associated with sickle cell anaemia …
[HTML][HTML] Pre-Pandemic cross-reactive immunity against SARS-CoV-2 among Central and West African populations
M Souris, L Tshilolo, D Parzy, L Lobaloba Ingoba… - Viruses, 2022 - mdpi.com
For more than two years after the emergence of COVID-19 (Coronavirus Disease-2019),
significant regional differences in morbidity persist. These differences clearly show lower …
significant regional differences in morbidity persist. These differences clearly show lower …